Meeting
2019 Genitourinary Cancers Symposium
Genomic analysis and clinical outcomes of Primary Gleason Pattern 5 (PG5) prostate cancer (PCa) treated with radical prostatectomy (RP).
Authors
Pedro Isaacsson Velho
Sidney Kimmel Comprehensive Cancer Center - Johns Hopkins Hospital, Baltimore, MD
Pedro Isaacsson Velho , Tamara L. Lotan , Mark Christopher Markowski , Emmanuel S. Antonarakis , Michael Anthony Carducci , Samuel R. Denmeade , Hao Wang , David Lim , Colin Pritchard , Mario A. Eisenberger
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 54)
DOI
10.1200/JCO.2019.37.7_suppl.54
Abstract #
54
Poster Bd #
C22
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Clinical outcomes and genomic analysis in patients with very high-risk clinically localized prostate cancer treated by radical prostatectomy.
First Author: Pedro Isaacsson Velho
Poster
2020 Genitourinary Cancers Symposium
A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.
First Author: Fatima Karzai
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2017 Genitourinary Cancers Symposium
Genomic mechanisms of resistance to neoadjuvant leuprolide plus abiraterone in locally advanced prostate cancer.
First Author: Adam G. Sowalsky